NCT04563767View on ClinicalTrials.gov

Feasibility - Infinitome

CompletedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

October 13, 2020

Study Completion Date

October 13, 2020

Conditions
Alzheimer Disease
Interventions
PROCEDURE

Infinitome

Added sequence of rs-fMRI.

Trial Locations (1)

55130

HealthPartners Neuroscience Center, Saint Paul

All Listed Sponsors
lead

HealthPartners Institute

OTHER

NCT04563767 - Feasibility - Infinitome | Biotech Hunter | Biotech Hunter